Literature DB >> 8495969

Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin).

B König1, W König.   

Abstract

Escherichia coli bacteria expressing mannose-resistant fimbriae/haemagglutination induced the production of substantial amounts of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) from a peripheral human lymphocyte, monocyte, basophil (LMB) cell suspension. In this regard, E. coli bacteria with S-mannose-resistant fimbriae/haemagglutination were the most potent inducers of IL-6 and TNF-alpha secretion, followed by the E. coli strain with P-mannose-resistant fimbriae/haemagglutination. The E. coli alpha-haemolysin did not stimulate cytokine release from human LMB. In fact, this toxin, at non-toxic concentrations, depressed the spontaneous as well as the E. coli-induced production of TNF-alpha, IL-6, IL-1 beta. Our results indicate that two mechanisms may contribute to the severity of E. coli infection: (a) stimulation of cytokine release by type-specific fimbriae/haemagglutination properties and (b) depression of immune response by the E. coli alpha-haemolysin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495969      PMCID: PMC1421883     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  45 in total

1.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  Rapid identification of monocytes in a mixed mononuclear cell preparation.

Authors:  S B Tucker; R V Pierre; R E Jordon
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

3.  Haemolysin contributes to virulence of extra-intestinal E. coli infections.

Authors:  R A Welch; E P Dellinger; B Minshew; S Falkow
Journal:  Nature       Date:  1981-12-17       Impact factor: 49.962

Review 4.  Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation.

Authors:  H Baumann; J Gauldie
Journal:  Mol Biol Med       Date:  1990-04

5.  Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release.

Authors:  S Bhakdi; M Muhly; S Korom; G Schmidt
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili.

Authors:  E Blumenstock; K Jann
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

7.  Effects of adhesins from mannose-resistant Escherichia coli on mediator release from human lymphocytes, monocytes, and basophils and from polymorphonuclear granulocytes.

Authors:  Y Ventur; J Scheffer; J Hacker; W Goebel; W König
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

8.  Signal transduction in human platelets and inflammatory mediator release induced by genetically cloned hemolysin-positive and -negative Escherichia coli strains.

Authors:  B König; W Schönfeld; J Scheffer; W König
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Quantitation of mRNA by the polymerase chain reaction.

Authors:  A M Wang; M V Doyle; D F Mark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory.

Authors:  S Ehlers; K A Smith
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  8 in total

1.  Lack of a role of cytotoxic necrotizing factor 1 toxin from Escherichia coli in bacterial pathogenicity and host cytokine response in infected germfree piglets.

Authors:  S Fournout; C M Dozois; M Odin; C Desautels; S Pérès; F Hérault; F Daigle; C Segafredo; J Laffitte; E Oswald; J M Fairbrother; I P Oswald
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Phasevarion-Regulated Virulence in the Emerging Pediatric Pathogen Kingella kingae.

Authors:  Yogitha N Srikhanta; Ka Yee Fung; Georgina L Pollock; Vicki Bennett-Wood; Benjamin P Howden; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

3.  Role of Pseudomonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes, and monocytes.

Authors:  B König; K E Jaeger; A E Sage; M L Vasil; W König
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

Review 4.  The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Authors:  Travis J Wiles; Matthew A Mulvey
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

5.  Effect of growth factors on Escherichia coli alpha-hemolysin-induced mediator release from human inflammatory cells: involvement of the signal transduction pathway.

Authors:  B König; W König
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Pore formation by the Escherichia coli alpha-hemolysin: role for mediator release from human inflammatory cells.

Authors:  B König; A Ludwig; W Goebel; W König
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

Review 7.  Kingella kingae RtxA Cytotoxin in the Context of Other RTX Toxins.

Authors:  Katerina Filipi; Waheed Ur Rahman; Adriana Osickova; Radim Osicka
Journal:  Microorganisms       Date:  2022-02-27

Review 8.  Bacterial Toxins Are a Never-Ending Source of Surprises: From Natural Born Killers to Negotiators.

Authors:  Maria Lopez Chiloeches; Anna Bergonzini; Teresa Frisan
Journal:  Toxins (Basel)       Date:  2021-06-17       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.